The National Science and Technology Council publishes a Framework for Nucleic Acid Synthesis Screening, which incorporates and supplements portions of the Screening Framework Guidance for Providers and Users of Synthetic Nucleic Acids as published by the U.S. Department of Health and Human Services. Instance attests that it adheres to each of the criteria in the Framework for Nucleic Acid Synthesis Screening. If the Company ceases to adhere to the framework, it will notify, within 72 hours, any federally funded customers and federal funding agencies to which it previously submitted an attestation.

For additional information, please contact hello@instance.bio

Last Updated: October 11, 2024